Clinical Trials Browser

Phase 2 × Liver Neoplasms × pasireotide × Clear all

NCT01488487 2016-04-07

Everolimus and Pasireotide (SOM230) in Patients With Advanced or Metastatic Hepatocellular Carcinoma

Phase 2 Completed

24 enrolled 17 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms